Manual handling injuries remain the leading cause of lost time among workers in the developed world, and the amounts paid for chronic musculoskeletal disorders (MSDs) are the highest of all workers’ compensations.
Bard Pharmaceuticals, a major producer of prolonged release medical products, is proud to be consistently included in the Sunday Times Top 100 Best Companies to Work For in the UK. Their Health and Safety team pride themselves on challenging preconceptions and taking a proactive and pragmatic approach to keeping people safe. Yet, for all the excellent work of the internal Health and Safety team, MSDs have remained a key business challenge. So Bard teamed up with dorsaVi to provide additional insights and unlock new ideas for risk reduction.
What they found was a game changer.
Fill out the form to read the full case study.
